Related Experiment Video
Updated: May 15, 2025
08:10
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
1.6K
Arrhythmic Risk Stratification in Patients with Arrhythmogenic Cardiomyopathy
Marisa Varrenti1, Eleonora Bonvicini2, Leandro Fabrizio Milillo1
1Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.
Diagnostics (Basel, Switzerland)
|May 14, 2025
Summary
Arrhythmogenic cardiomyopathy causes heart scarring, leading to dangerous arrhythmias and sudden death. This review analyzes key studies and developments in risk stratification for affected patients.
Area of Science:
- Cardiology
- Electrophysiology
- Genetic Heart Diseases
Background:
- Arrhythmogenic cardiomyopathy (ACM) involves myocardial replacement by fibrofatty tissue.
- This pathology is a primary cause of malignant ventricular arrhythmias and sudden cardiac death, particularly in younger individuals.
- Accurate risk stratification for arrhythmias in ACM patients is clinically crucial yet challenging.
Purpose of the Study:
- To conduct a comprehensive literature review on risk stratification in arrhythmogenic cardiomyopathy.
- To analyze significant studies and emerging developments in predicting arrhythmic events in ACM patients.
Main Methods:
- Systematic literature review.
- Analysis of key studies and recent advancements in risk stratification for arrhythmogenic cardiomyopathy.
Main Results:
- Identified critical factors and methodologies for assessing arrhythmic risk in ACM.
- Highlighted evolving strategies and challenges in clinical risk stratification.
Conclusions:
- Effective risk stratification is vital for managing arrhythmogenic cardiomyopathy patients.
- Ongoing research and analysis of new developments are essential for improving patient outcomes and preventing sudden cardiac death.
Keywords:
arrhythmic risk stratificationarrhythmogenic cardiomyopathycardiac arrhythmiasgeneticssudden deathMore Related Videos
Related Concept Videos
01:28Disturbances in Heart Rhythm
729
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
729
01:28Mechanism of Cardiac Arrhythmias
856
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
856
01:16ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
153
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
153
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
01:30Pulse rhythm
725
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
725
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
665
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
665